My WebLink
|
Help
|
About
|
Sign Out
Home
COM 0078.006 1996-1998
ClerkCouncil
>
Council Records
>
Communications
>
1996-1998
>
COM 0078.006 1996-1998
Metadata
Thumbnails
Annotations
Entry Properties
Last modified
5/12/2008 3:45:18 PM
Creation date
5/10/2008 7:41:21 PM
Metadata
Fields
Template:
Communications
Communications - Type
COM
Communications - Council Term
1996-1998
Communication
0078
Point
006
Author
Robert H. Faust, PH.D., Faust Bio-Agricultural Services, Inc.
Communications - Referred To
COUNCIL
Comments
Presented: Council - 2/7/97
Communications - File Code
HCC
Document Relationships
COM 0078.000 1996-1998
(Related)
Path:
\Council Records\Communications\1996-1998
There are no annotations on this page.
Document management portal powered by Laserfiche WebLink 9 © 1998-2015
Laserfiche.
All rights reserved.
/
35
PDF
Print
Pages to print
Enter page numbers and/or page ranges separated by commas. For example, 1,3,5-12.
After downloading, print the document using a PDF reader (e.g. Adobe Reader).
View images
View plain text
<br /> Feuat&o-Ayiculturel 5srwceo lnc. 4BOB-32B-9i60 ~$1131l97 G2:22 PM ~il14 <br /> intravenously, a dosage which rendered the rest of the participants <br /> unconscious. <br /> GHB, Alcohol and Alcoholism <br /> GHB shows great promise in the treatment of alcoholism. In Europe, one of <br /> its primary uses is to relieve withdrawal symptoms, cravings, and anxiety <br /> among alcoholics. <br /> UL <br /> In laboratory rats addicted to alcohol, withdrawal symptoms closely <br /> resemble <br /> those exhibited by humans, including tremors, convulsions, and <br /> hypersensitivity to sound. All of these symptoms were blocked by <br /> sufficiently high doses of GHB [Fadda, 1989]. Administration of GHB has <br /> also <br /> been found to prevent alcohol consumption among rats that voluntarily <br /> ingest <br /> alcohol [Fadda, 1989; Gallimberti, 1989]. <br /> In a rigorous, double-blind, placebo-controlled study conducted of human <br /> alcoholics, "nearly all withdrawal symptoms disappeared within two to <br /> seven <br /> hours" after administration of GHB. On asevere-moderate-mild-or-none <br /> scale, <br /> withdrawal symptoms remained below moderate during the entire period. <br /> The <br /> only side effect observed was slight, occasional, and transient dizziness. <br /> The researchers concluded, "the results clearly indicated that GHB is <br /> effective for the suppression of withdrawal symptoms in alcoholics" <br /> [Gallimberti, 1989]. <br /> Other Uses of GHB <br /> GHB has a decades long track record of use as a general anesthetic. <br /> Administered intravenously, an anesthetic dose of GHB is in the range of <br /> 4-5 <br /> grams fora 1 50-pound person [Vickers, 1969]. Its advantages as an <br /> anesthetic include low toxicity, relatively few contraindications, slowing <br /> of the heart rate without loss of blood pressure, the absence of irritation <br /> to the veins with intravenous administration, muscle relaxation, absence <br /> <br />
The URL can be used to link to this page
Your browser does not support the video tag.